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Heterogeneous activation mechanisms in the renal microvascu-
lature. Vascular smooth muscle cells in different renal microvas-
cular segments utilize different activation mechanisms to respond
to mechanical and vasoactive stimuli. L-type Ca21 channel block-
ers vasodilate primarily the preglomerular vascular resistance
component responsible for autoregulation. Local interstitial infil-
tration of Ca21 channel blockers increases glomerular pressure
and markedly reduces vascular responsiveness of the tubuloglo-
merular feedback mechanism. Ca21 channel blockers selectively
attenuate the afferent vasoconstrictor responses to increases in
perfusion pressure. Although both afferent and efferent arterioles
constrict in response to angiotensin II (Ang II), afferent but not
efferent constriction requires Ca21 influx through L-type Ca21
channels. Sensitivity of the preglomerular arterioles to Ang II is
also heterogeneous with the greatest sensitivity in glomerulus-
near, terminal segments. Adenosine triphosphate (ATP) is a
vasoconstrictor agonist that selectively activates Ca21 entry path-
ways in afferent arterioles but has no effect on efferent arterioles.
In isolated preglomerular smooth muscle cells, increasing extra-
cellular [KCl] increases intracellular Ca21 by stimulating voltage-
dependent Ca21 influx. Ang II, norepinephrine, and ATP also
elicit similar increases in intracellular Ca21. Mechanical and
agonist-induced voltage-dependent Ca21 influx is thus a primary
pathway in the control of cytosolic Ca21 in afferent arterioles.
Efferent arterioles, however, rely primarily on intracellular Ca21
mobilization and other Ca21 influx pathways.
Our knowledge of the activation and signal transduction
mechanisms regulating renal vascular smooth muscle has
increased dramatically during recent years, and many dif-
ferent vasoconstrictor- and vasodilator-mediated pathways
have been delineated [1, 2]. There is general consensus that
the pivotal step eliciting vasoconstriction involves increases
in cytosolic Ca21 [Ca21]i; however, there are many mech-
anisms that elicit increases in [Ca21]i that, in turn, activate
calmodulin and myosin light chain kinase. These mecha-
nisms can be separated into those involving increases in
cellular entry of Ca21 via membrane channels and those
primarily involving release of Ca21 from intracellular
stores. Various studies of the renal vasculature indicate
that the activation and signal transduction mechanisms
characterized in cultured vascular smooth muscle cells
(VSMC) and glomerular mesangial cells may not partici-
pate equally in all segments of the renal microcirculation.
The existence of differential activation mechanisms con-
tributes to segmental functional heterogeneity and thus
allows various mechanical and vasoactive stimuli to exert
selective actions in specific vascular segments. Of central
importance is the major role of voltage-dependent Ca21
channels in regulating vascular smooth muscle tone primar-
ily in preglomerular arterioles but not in efferent arterioles.
WHOLE-KIDNEY AND MICROPUNCTURE STUDIES
SUPPORTING DIFFERENTIAL ACTIVATION
MECHANISMS
In accord with the seminal studies by Thurau [3], whole-
kidney experiments have provided clear evidence for the
importance of preglomerular arterioles in the mechanism
of renal blood flow (RBF) autoregulation and the ability of
Ca21 channel blockers to attenuate markedly RBF auto-
regulatory capability [1, 4–6]. The effects of Ca21 channel
blockers were not particularly surprising because vasodila-
tation of most vascular beds by Ca21 channel blockers was
well known. The clue supporting the selectivity of different
signal transduction mechanisms is that the vasodilatation
caused by the Ca21 channel blockers is restricted to the
autoregulatory component of the renal vascular resistance.
These effects are illustrated in Figure 1. The effects of Ca21
channel blockers differ from those of other vasodilators
that also reduce the nonautoregulatory component of renal
vascular resistance [7]. Other vasodilatory stimuli, includ-
ing angiotensin converting enzyme inhibitors and angioten-
sin II (Ang II) receptor antagonists, do not interfere
significantly with autoregulatory capability [1, 5]. These
data suggested that the resistance component specifically
responsible for autoregulatory behavior is regulated pri-
marily by voltage dependent Ca21 channels, whereas the
remaining components of renal vascular resistance utilize
other mechanisms [1, 5, 8].
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Micropuncture studies provided further evidence that
Ca21 channel blockers act predominantly on the preglo-
merular vasculature and not the postglomerular arterioles.
Mitchell and Navar [9] employed a peritubular capillary
infusion technique in which the interstitium bathing the
vascular pole of the nephron being studied was infiltrated
with Ca21 channel blockers. As shown in Figure 2, peritu-
bular capillary infusion with the structurally different Ca21
channel blockers verapamil and nifedipine substantially
increased glomerular pressure, as estimated from stop-flow
pressure measurements, and markedly attenuated tubulo-
glomerular feedback (TGF) responses of both stop-flow
pressure and nephron glomerular filtration rate (GFR) to
increases in distal nephron perfusion rate. Other studies
demonstrated that Ca21 channel blockers increase GFR as
well as RBF and increase glomerular pressure to a greater
extent than other vasodilators [1, 10, 11]. Thus, whole-
kidney and micropuncture experiments indicate that phar-
macological blockade of voltage-dependent Ca21 channels
predominantly vasodilates preglomerular arterioles. These
results led to the hypothesis that both autoregulatory and
TGF-mediated vasoconstrictor responses are dependent
primarily on activation of voltage dependent Ca21 chan-
nels.
DIRECT OBSERVATIONS SUPPORTING
DIFFERENTIAL ACTIVATION MECHANISMS
Studies visualizing afferent and efferent arterioles in the
in vitro juxtamedullary nephron preparation, the hydrone-
phrotic kidney preparation, and isolated arterioles provide
direct evidence for the selective control of preglomerular
VSMC by voltage-gated Ca21 channels [1, 4, 12–15]. In
most studies, Ca21 channel blockers consistently vasodi-
lated preglomerular arterioles with minor or imperceptible
actions on efferent arterioles. In addition, Ca21 channel
blockers prevented the autoregulatory adjustments in af-
ferent arteriolar diameter in response to changes in perfu-
sion pressure [16]. These findings are consistent with in
vitro studies on isolated perfused afferent and efferent
arterioles in which membrane depolarization by high [KCl]
caused much greater constriction in afferent than in effer-
ent arterioles [13] and increased [Ca21]i in afferent but not
efferent arterioles [15]. The increase in [Ca21]i was due to
entry from extracellular sources because it did not occur
when extracellular Ca21 was reduced or when Ca21 chan-
nel blockers were added to the media. These results are
consistent with studies in freshly isolated VSMC from
preglomerular arterioles. These cells respond to KCl-in-
duced depolarization with increases in [Ca21]i. This re-
sponse does not occur when Ca21 is removed from the
bathing solution or when a Ca21 channel blocker is added
[17]. In addition, branching points of preglomerular arte-
rioles are enriched in L-type Ca21 channels [18].
From these and similar studies, it seems clear that the
vascular smooth muscle responses mediating the autoreg-
ulatory mechanism seen at the whole-kidney level and the
TGF mechanism observed in single nephrons are highly
dependent on Ca21 influx via voltage-dependent Ca21
channels. Although the initiating event leading to vasocon-
striction may also involve release of Ca21 from intracellular
stores, the major increase in [Ca21]i is accounted for by
Ca21 entry from the extracellular fluid. Nevertheless, it
should be recognized that other stimuli, which primarily
alter intracellular cGMP or cAMP levels, may modulate
basal vascular tone and reactivity [1, 19, 20]. Except at very
high concentrations, these agents do not impair renal
autoregulatory capability but change primarily the level of
operation or the plateau of autoregulation.
HETEROGENEITY OF ANGIOTENSIN II-INDUCED
ACTIVATION MECHANISMS IN AFFERENT AND
EFFERENT ARTERIOLES
That afferent and efferent arterioles are activated differ-
ently by Ang II was suggested by the whole-kidney obser-
vations that Ang II-mediated vasoconstriction is only partly
blocked by Ca21 channel blockers [5, 8]. More direct
studies in the in vitro juxtamedullary nephron preparation
showed that different mechanisms mediate the Ang II-
induced vasoconstrictor responses in afferent and efferent
arterioles [21]. As shown in Figure 3, Ca21 channel block-
ers such as verapamil and diltiazem block afferent arterio-
lar vasoconstriction responses to Ang II [21, 22]. In con-
trast, the ability of Ang II to constrict efferent arterioles is
not diminished by addition of Ca21 channel blockers, and
clear dose-dependent vasoconstrictor effects of Ang II are
maintained at control levels. In further studies, Ang II
vasoconstricted isolated perfused arterioles and increased
[Ca21]i in both afferent and efferent arterioles but through
different mechanisms [13, 23]. Again, Ca21 channel block-
ers prevent the sustained increase in [Ca21]i in afferent but
not efferent arterioles. The vasoconstrictor responses to
Fig. 1. Effects of Ca21 channel blockade (verapamil and nifedipine) on
renal blood flow autoregulatory capability. Symbols are: (E) control; (F)
calcium blockade. Figure is based on [5].
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Ang II and norepinephrine (NE) involve initial depolariza-
tion elicited by Cl2 channels [22]. In contrast, activation of
voltage-dependent Ca21 channels by increasing arterial
pressure does not require activation of Cl2 channels. These
data indicate the existence of multiple mechanisms that
lead to depolarization and activation of voltage-dependent
Ca21 channels in the preglomerular vasculature. Neverthe-
less, the afferent arteriolar responses to Ang II appear to
involve an initial step related to Ca21 release from intra-
cellular stores. Treatment with thapsigargin, which depletes
intracellular Ca21 stores, attenuates the vasoconstrictor
response of the afferent arteriole to Ang II [24]. Thapsi-
gargin also completely blocks the Ang II-mediated efferent
constriction, thus demonstrating the major reliance of the
efferent arterioles on intracellular Ca21 release. Interest-
ingly, thapsigargin blocks NE-mediated vasoconstrictor re-
sponses of both afferent and efferent arterioles.
Loutzenhiser et al recently evaluated the effects of Ang
II on membrane potential of VSMC in afferent and effer-
ent arterioles [14]. Ang II-induced vasoconstriction was
associated with membrane depolarization in afferent arte-
rioles, whereas efferent arterioles vasoconstricted but did
not depolarize on exposure to Ang II. De B Helou and
Marchetti [25] found both morphological and functional
heterogeneity: most of the efferent arterioles from outer
cortex are thin, whereas the inner cortex has both thin and
thick muscular efferent arterioles. Following exposure to
Ang II, the thin efferent arterioles of the outer cortex had
a smaller increase in [Ca21]i than the corresponding affer-
ent arterioles. Ang II-mediated Ca21 influx in thin efferent
arterioles from outer cortex was not blocked by nifedipine
but was inhibited by NiCl2, indicating that other Ca
21 entry
pathways may be activated by Ang II in efferent arterioles.
In efferent arterioles from inner cortex, Ca21 entry was
partly blocked by nifedipine but also by NiCl2. These
investigators pointed out that Ang II increases [Ca21]i in
afferent arterioles as much or more than in efferent
arterioles and concluded that Ang II regulates these renal
microcirculatory structures via different mechanisms.
Recently we have also demonstrated heterogeneity of
Fig. 2. Effects of peritubular capillary infusion
of Ca21 channel blockers on tubuloglomerular
feedback (TGF) responses to increases in distal
nephron perfusion rate. The magnitudes of the
TGF-mediated decreases in stop-flow pressure
(SFP) and single nephron filtration rate were
assessed before (F, control) and during
peritubular capillary infusion with Ca21 channel
blockers (M). Data are from [9].
Fig. 3. Afferent and efferent arteriolar
vasoconstrictor responses to angiotensin II
(Ang II) in the in vitro juxtamedullary nephron
preparation before (E) and after treatment
with Ca21 channel blockers (M). Data are from
[21].
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responsiveness along the length of the preglomerular vas-
culature. The reactivity of the terminal end of afferent
arterioles in response to changes in perfusion pressure
diminishes after interruption of TGF [16]. In contrast, the
reactivity of the earlier segment of the afferent arteriole to
changes in perfusion pressure was not greatly affected. The
reactivity to Ang II and NE also differs along the afferent
arteriole. Diameter responses to Ang II and NE were made
at early, mid, and terminal segments of afferent arterioles.
As shown in Figure 4, the vasoconstrictor responses to NE
are similar along the length of the arteriole, whereas the
Ang II-mediated vasoconstriction of the terminal portion
of afferent arterioles is significantly greater than in earlier
segments of the same arteriole [26]. These data suggest that
the segment of the afferent arteriole nearest the glomeru-
lus is more sensitive to Ang II and may contribute most to
Ang II-induced preglomerular resistance changes.
HETEROGENEITY OF RESPONSES TO PURINERGIC
STIMULI
The Ang II constriction and the NE-induced constriction
of afferent and efferent arterioles are examples of agents
that constrict both preglomerular and postglomerular arte-
rioles, but through different activation mechanisms. In
contrast, the vascular responses mediated by mechanical or
TGF-associated stimuli are examples of mechanisms that
act selectively at preglomerular sites. These findings dem-
onstrate that certain paracrine stimuli discriminate be-
tween the afferent and efferent arteriolar VSMC. The
findings that there is heterogeneity in the activation and
signaling mechanisms in afferent and efferent arterioles
provide one possible explanation for the selective action of
certain stimuli.
Investigations on the vascular actions of the purines,
adenosine, and adenosine triphosphate (ATP) reveal inter-
esting differences in the renal microcirculatory responses.
In particular, ATP-mediated stimulation of P2 receptors on
the renal vasculature affects mainly the afferent arterioles
[27]. ATP does not vasoconstrict efferent arterioles, imply-
ing either absence of P2 receptors or of the ATP-mediated
activation mechanism. ATP has been shown to exert its
vasoconstrictor actions primarily via activation of voltage-
dependent Ca21 channels [28], and vasoconstrictor re-
sponses are blocked by Ca21 channel blockers and also by
removal of extracellular Ca21. These results help explain
the functional heterogeneity with regard to the mainly
preglomerular effects of ATP.
The finding that ATP selectively affects preglomerular
arterioles via mechanisms linked to activation of voltage-
dependent Ca21 channels raises the intriguing possibility
that ATP or a paracrine agent acting similarly is responsi-
ble for the TGF-mediated afferent vasoconstrictor re-
sponses during increases in distal nephron perfusion rate or
during increases in arterial perfusion pressure. Microper-
fusion studies evaluating TGF responses during peritubular
capillary infusion with ATP or ATP analogues demonstrate
that saturating the P2 receptors markedly decreases the
magnitude of the TGF-mediated decreases in stop-flow
pressure during increases in distal nephron perfusion rate
[29]. In further experiments using the juxtamedullary
nephron preparation, the afferent arteriolar vasoconstric-
tor responses to increases in perfusion pressure were
markedly attenuated by procedures that desensitize or
saturate the P2 receptors or by P2 receptor antagonists [30].
Thus, both the micropuncture and the microcirculatory
experiments are consistent with the hypothesis that ATP or
a signaling mechanism that shares these selective preglo-
merular actions via voltage-dependent Ca21 channels pro-
vides the activating stimulus for the TGF and/or myogenic
mechanisms. Thus, the presence of segment-specific and
agonist-specific mechanisms allows precise regulation of
renal microvascular function.
Collectively, these studies demonstrate that voltage-
gated Ca21 channels play a predominant role in mediating
the increases in cell Ca21 and vasoconstriction in afferent
arterioles in response to various mechanical and paracrine
stimuli. These activation mechanisms play a major role in
mediating autoregulatory and tubuloglomerular feedback
responses. In contrast, the efferent arterioles respond more
heterogeneously but can be activated by Ca21 influx
through other pathways and by cellular mechanisms inde-
pendent of membrane depolarization, including Ca21 re-
lease from intracellular stores.
Fig. 4. Heterogeneity of afferent arteriolar vasoconstrictor responses to
angiotensin II (Ang II 10 nM; M) and norepinephrine (NE 200 nM; u) in
the in vitro juxtamedullary nephron preparation. During superfusion with
solutions containing Ang II or NE, early afferent arteriolar diameters were
measured 670 6 70 mm, midafferent sites 350 6 40 mm, and terminal sites
within 20 6 2 mm, from the glomerulus. Results from 16 afferent
arterioles, mean length 700 6 80 mm. Data are from [26].
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APPENDIX
Abbreviations used in this article are: ACE, angiotensin converting
enzyme; Ang II, angiotensin II; ATP, adenosine triphosphate; GFR,
glomerular filtration rate; NE, norepinephrine; RBF, renal blood flow;
TGF, tubuloglomerular feedback; VSMC, vascular smooth muscle cells.
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